Biotricity Inc (BTCY) - Total Liabilities
Based on the latest financial reports, Biotricity Inc (BTCY) has total liabilities worth $37.98 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Biotricity Inc - Total Liabilities Trend (2014–2025)
This chart illustrates how Biotricity Inc's total liabilities have evolved over time, based on quarterly financial data. See Biotricity Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Biotricity Inc Competitors by Total Liabilities
The table below lists competitors of Biotricity Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gore Street Energy Storage Fund Plc
LSE:GSF
|
UK | GBX666.94K |
|
Aurora Investment Trust plc
LSE:ARR
|
UK | GBX442.00K |
|
EQTEC plc
LSE:EQT
|
UK | £9.22 Million |
|
iTonic Holdings Ltd.
NASDAQ:ITOC
|
USA | $969.83K |
|
Pinnacle Minerals Ltd
AU:PIM
|
Australia | AU$243.62K |
|
Prostatype Genomics AB
ST:PROGEN
|
Sweden | Skr7.36 Million |
|
De La Rue PLC
LSE:DLAR
|
UK | GBX298.90 Million |
|
STL Global Limited
NSE:SGL
|
India | Rs287.89 Million |
Liability Composition Analysis (2014–2025)
This chart breaks down Biotricity Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Biotricity Inc.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 6.01 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Biotricity Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Biotricity Inc (2014–2025)
The table below shows the annual total liabilities of Biotricity Inc from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $35.66 Million | -0.74% |
| 2024-03-31 | $35.92 Million | +36.29% |
| 2023-03-31 | $26.36 Million | +40.02% |
| 2022-03-31 | $18.82 Million | +67.00% |
| 2021-03-31 | $11.27 Million | +125.21% |
| 2020-03-31 | $5.00 Million | +120.64% |
| 2019-03-31 | $2.27 Million | +199.97% |
| 2018-03-31 | $756.18K | -84.44% |
| 2017-03-31 | $4.86 Million | +176.31% |
| 2016-03-31 | $1.76 Million | +876.82% |
| 2015-03-31 | $180.00K | +5.53% |
| 2014-03-31 | $170.56K | -- |
About Biotricity Inc
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes … Read more